 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Anemia
See also: Fatigue & HIV
Overview
- A Clinical Overview of Epoetin Alfa (Epogen, Procrit) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - Challenging Cases in HIV: Implications of Anemia (November 29, 2006)
A slide presentation with audio of a case-study by Douglas T. Dieterich, M.D., reviewing the incidence and impact of anemia in HIV-infected patients; to view only the slides, without the audio, click here.
From The Body PRO - Challenging Cases in HIV: Implications of Anemia (November 29, 2006)
A slide presentation with audio of a case-study by David H. Henry, M.D., reviewing the incidence and impact of anemia in HIV-infected patients; to view only the slides, without the audio, click here.
From The Body PRO - Longer Dosing Intervals of Epoetin Alfa Are Effective in Maintaining Hemoglobin Levels in Anemic, HIV-Infected Patients (September 17, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - Hydroxyurea in the Treatment of HIV-1 (January 2000)
In Annals of Pharmacotherapy
  |
  |